Company Number: 14850310

Analysis Date: 2025-07-29 17:51 UTC

1. Credit Opinion: DECLINE
   COSZUS LTD is a newly incorporated micro-entity with limited financial history and a negative net asset position as of its first year-end. The company shows a balance sheet deficit (£-847) primarily due to long-term liabilities surpassing total assets. This indicates a weak capital structure and potential funding difficulties. There is no evidence of positive operating cash flow or profitability yet, increasing risk that the company may struggle to meet debt obligations. Given the early stage of the business, minimal tangible assets, and negative equity, the company does not currently demonstrate adequate financial strength or resilience to support new credit facilities.

2. Financial Strength:
   The company has no fixed assets and only modest current assets (£1,651) primarily in cash or equivalents. Current liabilities are reported as zero, but long-term liabilities total £2,500, pushing net assets negative. Shareholders’ funds are also negative at £-847, signaling that liabilities exceed assets. The balance sheet is weak with a lack of tangible collateral or retained earnings. The micro-entity status and small employee base (2 employees) reflect a very early-stage operation with limited scale.

3. Cash Flow Assessment:
   Available data does not provide a formal cash flow statement, but the minimal current assets and presence of long-term liabilities suggest constrained liquidity. The positive net current assets figure (£1,651) conflicts with the negative total net assets, implying some short-term liquidity but insufficient to cover all obligations. The company’s ability to generate positive cash flow is unproven and likely limited given its size and recent incorporation. Working capital appears minimal and fragile.

4. Monitoring Points:

• Improvement or deterioration in net asset position in future filings
• Evidence of positive operating cash flow and profitability
• Changes in capital structure, including new equity injections or debt repayments
• Timely filing of future accounts and confirmation statements
• Any changes in director appointments or ownership structure that may impact governance or control